Chenomx Inc

Chenomx Inc is a software company headquartered in Edmonton, Canada, specializing in leveraging nuclear magnetic resonance (NMR) spectroscopy to generate and analyze metabolic information from biological fluids. The company's innovative platform, Chenomx NMR Suite, is designed to aid researchers in correlating metabolic responses with various factors such as pathology, drug efficacy, and genetics. Chenomx boasts an extensive library containing over 300 metabolites to support NMR instruments ranging from 400MHz to 800MHz, offering a comprehensive resource for metabolic analysis.

By combining cutting-edge spectroscopic processing techniques and advanced algorithms, Chenomx facilitates the identification of metabolic markers and the analysis of biological samples with precision. The company's method involves both theoretical and empirical data, tailored to adjust to different NMR field strengths and sample conditions for accurate spectrum matching. Chenomx is dedicated to providing scientists with a powerful toolset for in-depth metabolite analysis and interpretation.

Generated from the website content